Limitations in the conventional assessment of the incremental value of predictors of cardiovascular risk
Authors:
- Michael PencinaMPMichael Pencina
- George ThanassoulisGTGeorge Thanassoulis
- 1 June 2015
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Lipidology
- Vol. 26 (3) , 210-214
Abstract
Whether a factor significantly increases the area under the curve (AUC) of a receiver operating characteristic analysis has become the standard test of its utility. Thus, in many studies, apolipoprotein B and LDL particle number have not increased the AUC significantly beyond that produced by the conventional markers, and guideline groups have concluded on this basis that they should not be added to routine clinical practice. This article demonstrates this conclusion to be invalid. In conventional analyses, no distinctions have been drawn as to whether a novel predictor is causal or whether it is highly correlated with other markers already included in the risk algorithm. However, correlation among the markers will profoundly affect the incremental effect of a factor on the AUC. This distinction is particularly critical for factors that have been shown to play a causal role in the production of clinical event. Accordingly, the AUC approach is valid to determine the total discriminatory ability of a set of variables but is not appropriate to allocate attributable risk among the members of the set. For correlated predictors that describe different aspects of the same variable such as non-HDL-C and apoB or LDL-C and LDL particle number, discordance analysis offers a simple valid alternative to capture and compare the independent information contained by each predictor.Keywords
This publication has 14 references indexed in Scilit:
- Hyperlipidemia in Early Adulthood Increases Long-Term Risk of Coronary Heart DiseaseCirculation, 2015
- Discordance of Low-Density Lipoprotein (LDL) Cholesterol With Alternative LDL-Related Measures and Future Coronary EventsCirculation, 2014
- Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: Rationale and Design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)American Heart Journal, 2011
- Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant dataBMJ, 2011
- Genetic Loci Associated With C-Reactive Protein Levels and Risk of Coronary Heart DiseaseJAMA, 2009
- Criteria for Evaluation of Novel Markers of Cardiovascular RiskCirculation, 2009
- Age as a modifiable risk factor for cardiovascular diseaseThe Lancet, 2008
- Clinical Utility of Different Lipid Measures for Prediction of Coronary Heart Disease in Men and WomenJAMA, 2007
- Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and DeathNew England Journal of Medicine, 2006
- Comparison of the Associations of Apolipoprotein B and Non-High-Density Lipoprotein Cholesterol With Other Cardiovascular Risk Factors in Patients With the Metabolic Syndrome in the Insulin Resistance Atherosclerosis StudyCirculation, 2004